SMi's Controlled Release conference held on 28th & 29th March 2012, London

How to select the most apporpriate formulation tool for poorly soluble drugs
 
 
Untitled-1
Untitled-1
 
Spread the Word
Listed Under

Tags:
Nanomedicine
Formulation
Drug Delivery
Nanocrystals
Cardiovascular

Industry:
• Pharmaceuticals

Location:
England

Nov. 24, 2011 - PRLog -- As formulation and delivery for small molecule and biologics becomes ever more important, targeted delivery and lifecycle extension remain an ongoing need for all concerned.  Advances in nanomedicine are meeting these challenges to deliver increasingly sophisticated medicines for oral, parenteral and transdermal extended release therapeutics.  

Don’t miss out on this fantastic opportunity to network with experts in the field such as:

•   Peter Timmins, Executive Director, Drug Products, Science and Technology, Bristol-Myers Squibb
•   Simon Holland, Director, Process Understanding & Control, GlaxoSmithKline
•   Bernd Riebesehl, Principal Fellow, Parenteral Dosage Forms, Pharmaceutical and Analytical Development, Novartis
•   Mostafa Nakach, Head of the Pharmaceutical Engineering Group, Sanofi-Aventis
•   Michael Keller, Senior Fellow, siRNA Project Leader, Technical Research and Development (TRD), Novartis
•   Tomas Landh, Director, Novo Nordisk
•   Jan L. Powell, Director, Physiology, Shire HGT
•   Lars Bauer, Senior Medical Director, Therapeutic Area CNS, UCB
•   Karin Liltorp, Director, Preformulation, Lundbeck
•   Mario Maio, Director of Formulation & Process Development, Merck Serono
•   Bernardo Perez-Ramírez, Senior Scientific Director, BioFormulations Development, Genzyme
•   Marcio Temtem, Process Development Engineer, Hovione

There will also be two interactive pre-conference workshops held on the 27th March 2012 on.....

A.  Accelerating first-in-human studies (FIH) with lipid-based formulations
    Hosted by: David J. Hauss, Principal, Hauss Associates
    Hassan Benameur, Senior Director Pharmaceutical Sciences, Capsugel
    Senior Representative, Gattefossé
    8.30am-12.30pm

B.  A trip through the life and work of a patent
    Hosted by: Jonathan Couchman, Partner, Harrison Goddard Foote (HGF) & Martyn Fish, Partner, HGF Law
    1.30pm-5.30pm

For more information and to book your place visit http://www.smi-online.co.uk/controlledrelease23.asp

Alternatively, contact Andrew Gibbons at Tel: +44 (0)20 7827 6156 or Email: agibbons@smi-online.co.uk
End
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Nanomedicine, Formulation, Drug Delivery, Nanocrystals, Cardiovascular
Industry:Pharmaceuticals
Location:England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. PRs
Trending News
Top Daily News
Top Weekly News



Like PRLog?
9K2K1K
Click to Share